Pharmac Funds New ADHD Medication and Removing Renewal Criteria for Funded Treatments w/ ADHD New Zealand’s Darrin Bull: 12 November, 2024

Pharmac has announced the funding of the ADHD medication Lisdexamfetamine, which is currently not available in the country, as well as removing the renewal criteria for funded treatments.

The new medication will be funded from December, which is expected to benefit over 6000 people.

Many have welcomed these developments, including ADHD New Zealand.

News and Editorial Director, Joel, spoke to the spokesperson from the organisation, Darrin Bull, about these developments, and why they are so important for Aotearoa’s ADHD community.